Phenibut

Phenibut is the common name for beta-phenyl-gamma-aminobutyric acid, also written beta-phenyl-GABA, a central nervous system depressant and nootropic that is essentially the inhibitory neurotransmitter GABA with a phenyl ring added at the beta position ^[1][3]. That aromatic ring is the defining chemical feature, because it makes the molecule lipophilic enough to cross the blood-brain barrier, something unmodified GABA cannot do efficiently, allowing orally taken phenibut to reach central GABA receptors ^[1][3]. It is closely related to baclofen, which is essentially phenibut with a chlorine atom added to the phenyl ring, and the two share much of their pharmacology ^[1].

Phenibut was discovered and introduced into clinical practice in the Soviet Union in the 1960s, where it was used to relieve tension, anxiety, and fear, to improve sleep in psychosomatic and neurotic patients, and as a pre-operative or post-operative medication ^[1]. In Russian medicine it has also been applied to conditions marked by asthenia and depression, and to post-traumatic stress, stuttering, and vestibular disorders ^[1]. Its reported effects combine anxiolytic, or tension-relieving, and nootropic, or cognition-supporting, actions, and its psychopharmacological profile has been likened both to baclofen and, for its calming quality, to tranquilizers such as diazepam ^[1][3].

Outside the former Soviet states phenibut is not an approved medicine. In the United States the Food and Drug Administration has never approved it as a drug and has warned that it is not a lawful dietary ingredient, yet it continues to be sold online as a supplement marketed for nootropic and relaxation purposes ^[3][5]. Analytical work has found wide and inconsistent amounts of phenibut in over-the-counter products, in some cases far exceeding a typical pharmaceutical dose ^[5]. It is most often encountered as a free-amino-acid powder or as the hydrochloride salt, and a fluorinated analogue sold as F-phenibut is also available from online suppliers ^[1][2]. Poison-center reports and published case series document that intoxication, dependence, and a withdrawal syndrome can accompany heavy or prolonged use, and this clinical experience frames much of the modern literature on the compound ^[3][4][6].

Phenibut is a GABA-B agonist with a well-documented risk of tolerance, dependence, and a severe withdrawal syndrome (anxiety, insomnia, agitation, and in serious cases psychosis or seizures) that can follow even a few weeks of regular use. It causes sedation and, especially when combined with alcohol, benzodiazepines, or opioids, can dangerously depress breathing and consciousness. Overdose and difficult withdrawals are frequently reported, and it is not an approved medicine in most countries.

As a GABA-B receptor agonist, phenibut produces additive central nervous system and respiratory depression when combined with alcohol, benzodiazepines, opioids, gabapentinoids, or baclofen, and published case reports describe severe sedation, respiratory depression, and delirium from such combinations. Its pharmacology overlaps baclofen, so concurrent use compounds GABA-B mediated effects and complicates withdrawal, which itself can present as a severe benzodiazepine-like syndrome managed in case reports with baclofen or benzodiazepines. Reports also describe interactions in the setting of polydrug use where phenibut deepened the sedation of other depressants. Because phenibut is an unapproved substance, these interactions derive from case reports and toxicology literature rather than a regulatory label. This is research information, not medical advice.

Checking a whole stack? Run it through interactions + stacks.

Phenibut was developed in the Soviet Union in the early 1960s at the Herzen Leningrad Pedagogical Institute, where a team associated with Professor Vsevolod Perekalin synthesized it by adding a phenyl ring to GABA so the molecule could cross the blood-brain barrier. It entered Soviet clinical practice as an anxiolytic and was famously included in the Soviet cosmonaut medical kit because it calmed nerves without impairing performance. For decades it was prescribed across Eastern Europe for anxiety, insomnia, and stress-related conditions. In more recent years it has spread internationally as an over-the-counter nootropic, which has also drawn attention to its risks of tolerance and dependence.

Phenibut is widely recognized as one of the most effective GABAergic anxiolytics available without a prescription, valued for producing calm, sociability, and easier sleep. Its heritage as a Soviet clinical medicine and cosmonaut aid lends it credibility, and its GABA-B mechanism is well characterized. Responsible discussion is equally clear about its liabilities: because GABA-B signaling adapts with regular use, tolerance builds quickly, and abrupt discontinuation after sustained dosing can cause a serious withdrawal syndrome. A systematic review found that at therapeutic doses phenibut is generally safe and well tolerated, with problems concentrated among high-dose, online-sourced use; it is best approached with infrequent dosing and respect for its dependence potential.